168 related articles for article (PubMed ID: 22095238)
1. An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.
Vermeulen I; Weets I; Costa O; Asanghanwa M; Verhaeghen K; Decochez K; Ruige J; Casteels K; Wenzlau J; Hutton JC; Pipeleers DG; Gorus FK;
Diabetologia; 2012 Feb; 55(2):413-20. PubMed ID: 22095238
[TBL] [Abstract][Full Text] [Related]
2. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
3. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.
De Grijse J; Asanghanwa M; Nouthe B; Albrecher N; Goubert P; Vermeulen I; Van Der Meeren S; Decochez K; Weets I; Keymeulen B; Lampasona V; Wenzlau J; Hutton JC; Pipeleers D; Gorus FK;
Diabetologia; 2010 Mar; 53(3):517-24. PubMed ID: 20091020
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
5. Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
Bosi E; Boulware DC; Becker DJ; Buckner JH; Geyer S; Gottlieb PA; Henderson C; Kinderman A; Sosenko JM; Steck AK; Bingley PJ;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2881-2886. PubMed ID: 28531305
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.
Asanghanwa M; Gorus FK; Weets I; der Auwera BV; Aminkeng F; Mbunwe E; Goubert P; Verhaeghen K; Sobngwi E; Wenzlau JM; Hutton JC; Pipeleers DG; Keymeulen B; Mbanya JC; van Schravendijk C
Diabetes Res Clin Pract; 2014 Jan; 103(1):97-105. PubMed ID: 24332797
[TBL] [Abstract][Full Text] [Related]
8. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
[TBL] [Abstract][Full Text] [Related]
9. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
10. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
13. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
15. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
[TBL] [Abstract][Full Text] [Related]
16. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
[TBL] [Abstract][Full Text] [Related]
17. Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
Vermeulen I; Weets I; Asanghanwa M; Ruige J; Van Gaal L; Mathieu C; Keymeulen B; Lampasona V; Wenzlau JM; Hutton JC; Pipeleers DG; Gorus FK;
Diabetes Care; 2011 Aug; 34(8):1760-5. PubMed ID: 21715527
[TBL] [Abstract][Full Text] [Related]
18. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
[TBL] [Abstract][Full Text] [Related]
19. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.
Long AE; Gooneratne AT; Rokni S; Williams AJ; Bingley PJ
J Clin Endocrinol Metab; 2012 Feb; 97(2):632-7. PubMed ID: 22162482
[TBL] [Abstract][Full Text] [Related]
20. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.
Yu L; Boulware DC; Beam CA; Hutton JC; Wenzlau JM; Greenbaum CJ; Bingley PJ; Krischer JP; Sosenko JM; Skyler JS; Eisenbarth GS; Mahon JL;
Diabetes Care; 2012 Jun; 35(6):1213-8. PubMed ID: 22446173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
